Associations between outcome variables of nutritional screening methods and systemic treatment tolerance in patients with colorectal cancer: A systematic review



      Multiple screening methods for malnutrition are available, but a systematic review of evidence in patients with colorectal cancer (CRC) is lacking. The aim of this study is to systematically investigate which outcome variables of nutritional screening methods are associated with treatment tolerance in patients with CRC.

      Material and Methods

      A systematic review was performed with respect to outcome variables of nutritional screening methods and their association with systemic treatment tolerance in patients with CRC. The Cochrane guidelines for systematic reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Two authors independently assessed the risk of bias and quality of each included study.


      A total of sixteen studies were included. The following screening methods for malnutrition were assessed in the included studies: serum albumin, body mass index, C-reactive protein/albumin ratio, modified version of the Glasgow prognostic score, mini nutritional assessment, nutritional risk index, patient-generated subjective global assessment, sarcopenia and weight loss.


      Sarcopenia tended to be associated with treatment tolerance more often than other screening methods but the current review suggests that there are ample screening methods rendering meaningful outcomes regarding a patient's nutritional status and associated risk for treatment intolerance. This grants practitioners the flexibility to choose from a variety of different nutritional screening methods. Nutritional screening can thus be tailored to the individual patient. Importantly, nutritional screening may help identify those patients at risk for chemotoxicity thus allowing for the implementation of targeted prehabilitation programs in order to prevent (severe) chemotoxicity.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • Jemal A.
        Cancer statistics, 2022.
        CA Cancer J Clin. 2022; 72: 7-33
        • Grothey A.
        • Sobrero A.F.
        • Shields A.F.
        • Yoshino T.
        • Paul J.
        • Taieb J.
        • et al.
        Duration of adjuvant chemotherapy for stage III Colon Cancer.
        N Engl J Med. 2018; 378: 1177-1188
        • Heinemann V.
        • von Weikersthal L.F.
        • Decker T.
        • Kiani A.
        • Vehling-Kaiser U.
        • Al-Batran S.E.
        • et al.
        FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
        Lancet Oncol. 2014; 15: 1065-1075
        • O’Connor E.S.
        • Greenblatt D.Y.
        • LoConte N.K.
        • Gangnon R.E.
        • Liou J.I.
        • Heise C.P.
        • et al.
        Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
        J Clin Oncol. 2011; 29: 3381-3388
        • Cijfers over kanker [Internet]
        Netherlands Cancer Registry.
        (Available from)
        • Lee C.S.
        • Ryan E.J.
        • Doherty G.A.
        Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation.
        World J Gastroenterol. 2014; 20: 3751-3761
        • Williams G.R.
        • Al-Obaidi M.
        • Dai C.
        • Mir N.
        • Challa S.A.
        • Daniel M.
        • et al.
        Association of malnutrition with geriatric assessment impairments and health-related quality of life among older adults with gastrointestinal malignancies.
        Cancer. 2020; 126: 5147-5155
        • Van Den Broeke C.
        • De Burghgraeve T.
        • Ummels M.
        • Gescher N.
        • Deckx L.
        • Tjan-Heijnen V.
        • et al.
        Occurrence of malnutrition and associated factors in community-dwelling older adults: those with a recent diagnosis of cancer are at higher risk.
        J Nutr Health Aging. 2018; 22: 191-198
        • Hill A.
        • Kiss N.
        • Hodgson B.
        • Crowe T.C.
        • Walsh A.D.
        Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients.
        Clin Nutr. 2011; 30: 92-98
        • Hu W.H.
        • Cajas-Monson L.C.
        • Eisenstein S.
        • Parry L.
        • Cosman B.
        • Ramamoorthy S.
        Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: an analysis of ACS-NSQIP.
        Nutr J. 2015; 14: 91
        • Extermann M.
        • Hurria A.
        Comprehensive geriatric assessment for older patients with cancer.
        J Clin Oncol. 2007; 25: 1824-1831
        • Aaldriks A.A.
        • van der Geest L.G.
        • Giltay E.J.
        • le Cessie S.
        • Portielje J.E.
        • Tanis B.C.
        • et al.
        Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy.
        J Geriatr Oncol. 2013; 4: 218-226
        • Caillet P.
        • Liuu E.
        • Raynaud Simon A.
        • Bonnefoy M.
        • Guerin O.
        • Berrut G.
        • et al.
        Association between cachexia, chemotherapy and outcomes in older cancer patients: a systematic review.
        Clin Nutr. 2017; 36: 1473-1482
        • Sealy M.J.
        • Nijholt W.
        • Stuiver M.M.
        • van der Berg M.M.
        • Roodenburg J.L.
        • van der Schans C.P.
        • et al.
        Content validity across methods of malnutrition assessment in patients with cancer is limited.
        J Clin Epidemiol. 2016; 76: 125-136
        • Torbahn G.
        • Strauss T.
        • Sieber C.C.
        • Kiesswetter E.
        • Volkert D.
        Nutritional status according to the mini nutritional assessment (MNA)® as potential prognostic factor for health and treatment outcomes in patients with cancer - a systematic review.
        BMC Cancer. 2020; 20: 594
        • van Abbema D.L.
        • van den Akker M.
        • Janssen-Heijnen M.L.
        • van den Berkmortel F.
        • Hoeben A.
        • de Vos-Geelen J.
        • et al.
        Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: a systematic review.
        J Geriatr Oncol. 2019; 10: 31-41
        • Cumpston M.
        • Li T.
        • Page M.J.
        • Chandler J.
        • Welch V.A.
        • Higgins J.P.
        • et al.
        Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
        Cochrane Database Syst Rev. 2019; 10 (Ed000142)
        • Page M.J.
        • McKenzie J.E.
        • Bossuyt P.M.
        • Boutron I.
        • Hoffmann T.C.
        • Mulrow C.D.
        • et al.
        The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
        Int J Surg. 2021; 88105906
        • Eriksen M.B.
        • Frandsen T.F.
        The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review.
        J Med Libr Associat JMLA. 2018; 106: 420
        • Zubrod C.G.
        • Schneiderman M.
        • Frei III, E.
        • Brindley C.
        • Gold G.L.
        • Shnider B.
        • et al.
        Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide.
        J Chronic Dis. 1960; 11: 7-33
        • Stang A.
        Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.
        Eur J Epidemiol. 2010; 25: 603-605
        • Antonio M.
        • Carmona-Bayonas A.
        • Saldaña J.
        • Navarro V.
        • Tebé C.
        • Salazar R.
        • et al.
        Factors predicting adherence to a tailored-dose adjuvant treatment on the basis of geriatric assessment in elderly people with colorectal Cancer: a prospective study.
        Clin Colorectal Cancer. 2018; 17: e59-e68
        • Barret M.
        • Antoun S.
        • Dalban C.
        • Malka D.
        • Mansourbakht T.
        • Zaanan A.
        • et al.
        Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer.
        Nutr Cancer. 2014; 66: 583-589
        • Barret M.
        • Malka D.
        • Aparicio T.
        • Dalban C.
        • Locher C.
        • Sabate J.M.
        • et al.
        Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study.
        Oncology. 2011; 81: 395-402
        • Chemama S.
        • Bayar M.A.
        • Lanoy E.
        • Ammari S.
        • Stoclin A.
        • Goéré D.
        • et al.
        Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
        Ann Surg Oncol. 2016; 23: 3891-3898
        • Decoster L.
        • Kenis C.
        • Naessens B.
        • Houbier G.
        • De Man M.
        • Lambrecht G.
        • et al.
        Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: results of a prospective observational cohort study (AVAPLUS).
        J Geriatric Oncol. 2018; 9: 93-101
        • Decoster L.
        • Vanacker L.
        • Kenis C.
        • Prenen H.
        • Van Cutsem E.
        • Van Der Auwera J.
        • et al.
        Relevance of geriatric assessment in older patients with colorectal cancer.
        Clin Colorectal Cancer. 2017; 16 (e221-e9)
        • Gallois C.
        • Artru P.
        • Lièvre A.
        • Auclin E.
        • Lecomte T.
        • Locher C.
        • et al.
        Evaluation of two nutritional scores’ association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study.
        Eur J Cancer. 2019; 119: 35-43
        • Gallois C.
        • Bourillon C.
        • Auclin E.
        • Artru P.
        • Lièvre A.
        • Lecomte T.
        • et al.
        Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: an AGEO prospective multicenter study.
        Clin Res Hepatol Gastroenterol. 2021; 45101603
        • Karabulut S.
        • Dogan I.
        • Usul Afsar C.
        • Karabulut M.
        • Karaman S.
        • Ferhatoglu F.
        • et al.
        Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study.
        J Oncol Pharm Pract. 2020; 27 (1078155220959427): 1357-1363
        • Okada S.
        • Yamazaki S.
        • Kaiga T.
        • Funada T.
        • Kochi M.
        • Takayama T.
        Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy.
        World J Surg Oncol. 2017; 15: 162
        • Retornaz F.
        • Guillem O.
        • Rousseau F.
        • Morvan F.
        • Rinaldi Y.
        • Nahon S.
        • et al.
        Predicting chemotherapy toxicity and death in older adults with Colon Cancer: results of MOST study.
        Oncologist. 2020; 25: e85-e93
        • Tominaga T.
        • Nonaka T.
        • Sumida Y.
        • Hidaka S.
        • Sawai T.
        • Nagayasu T.
        The C-reactive protein to albumin ratio as a predictor of severe side effects of adjuvant chemotherapy in stage III colorectal cancer patients.
        PLoS One. 2016; 11e0167967
        • Tsuchihashi K.
        • Ito M.
        • Moriwaki T.
        • Fukuoka S.
        • Taniguchi H.
        • Takashima A.
        • et al.
        Role of predictive value of the modified Glasgow prognostic score for later-line chemotherapy in patients with metastatic colorectal cancer.
        Clin Colorectal Cancer. 2018; 17 (e687-e97)
        • Nagata T.
        • Nakase Y.
        • Nakamura K.
        • Sougawa A.
        • Mochiduki S.
        • Kitai S.
        • et al.
        Prognostic impact of a nutritional index including muscle volume in stage 4 colorectal cancer.
        In Vivo. 2016; 30: 885-891
        • Gökyer A.
        • Küçükarda A.
        • Köstek O.
        • Hacıoğlu M.
        • Sunal B.
        • Demircan N.
        • et al.
        Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib.
        Clin Transl Oncol. 2019; 21: 1518-1523
        • Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 [Internet]
        (Available from)
        • Andreyev H.J.
        • Norman A.R.
        • Oates J.
        • Cunningham D.
        Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?.
        Eur J Cancer. 1998; 34: 503-509
        • Hull H.
        • Thornton J.
        • Wang J.
        • Pierson R.
        • Kaleem Z.
        • Pi-Sunyer X.
        • et al.
        Fat-free mass index: changes and race/ethnic differences in adulthood.
        Int J Obes. 2011; 35: 121-127
        • Burden S.T.
        • Hill J.
        • Shaffer J.L.
        • Todd C.
        Nutritional status of preoperative colorectal cancer patients.
        J Hum Nutr Diet. 2010; 23: 402-407
        • Prado C.M.
        • Baracos V.E.
        • McCargar L.J.
        • Mourtzakis M.
        • Mulder K.E.
        • Reiman T.
        • et al.
        Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
        Clin Cancer Res. 2007; 13: 3264-3268
        • Nazha B.
        • Moussaly E.
        • Zaarour M.
        • Weerasinghe C.
        • Azab B.
        Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate?.
        World J Gastrointest Surg. 2015; 7: 370-377
        • Boonpipattanapong T.
        • Chewatanakornkul S.
        Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas.
        J Clin Gastroenterol. 2006; 40: 592-595
        • Fuhrman M.P.
        The albumin-nutrition connection: separating myth from fact.
        Nutrition. 2002; 18: 199-200
        • Alberici Pastore C.
        • Paiva Orlandi S.
        • González M.C.
        Association between an inflammatory-nutritional index and nutritional status in cancer patients.
        Nutr Hosp. 2013; 28: 188-193
        • Guthrie G.J.
        • Charles K.A.
        • Roxburgh C.S.
        • Horgan P.G.
        • McMillan D.C.
        • Clarke S.J.
        The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.
        Crit Rev Oncol Hematol. 2013; 88: 218-230
        • Kinoshita A.
        • Onoda H.
        • Imai N.
        • Iwaku A.
        • Oishi M.
        • Tanaka K.
        • et al.
        The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
        Ann Surg Oncol. 2015; 22: 803-810
        • McMillan D.C.
        The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer.
        Cancer Treat Rev. 2013; 39: 534-540
        • Salas S.
        • Deville J.-L.
        • Giorgi R.
        • Pignon T.
        • Bagarry D.
        • Barrau K.
        • et al.
        Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma.
        Radiother Oncol. 2008; 87: 195-200
        • Ryu S.W.
        • Kim I.H.
        Comparison of different nutritional assessments in detecting malnutrition among gastric cancer patients.
        World J Gastroenterol: WJG. 2010; 16: 3310
        • Extermann M.
        • Boler I.
        • Reich R.R.
        • Lyman G.H.
        • Brown R.H.
        • DeFelice J.
        • et al.
        Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score.
        Cancer. 2012; 118: 3377-3386
        • Volkert D.
        • Beck A.M.
        • Cederholm T.
        • Cruz-Jentoft A.
        • Goisser S.
        • Hooper L.
        • et al.
        ESPEN guideline on clinical nutrition and hydration in geriatrics.
        Clin Nutr. 2019; 38: 10-47
        • Ræder H.
        • Henriksen C.
        • Bøhn S.K.
        • OdFV A.R.
        • Henriksen H.B.
        • Kværner A.S.
        • et al.
        Agreement between PG-SGA category and fat-free mass in colorectal cancer patients.
        Clin Nutr ESPEN. 2018; 27: 24-31
        • Lieffers J.
        • Bathe O.
        • Fassbender K.
        • Winget M.
        • Baracos V.
        Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery.
        Br J Cancer. 2012; 107: 931-936
        • Kurk S.
        • Peeters P.
        • Stellato R.
        • Dorresteijn B.
        • de Jong P.
        • Jourdan M.
        • et al.
        Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.
        J Cachexia Sarcopenia Muscle. 2019; 10: 803-813
        • Kurk S.
        • Peeters P.
        • Stellato R.
        • Dorresteijn B.
        • Jourdan M.
        • Creemers G.-J.
        • et al.
        Impact of sarcopenia on dose limiting toxicities in metastatic colorectal cancer patients (mCRC pts) receiving palliative systemic treatment.
        Ann Oncol. 2017; 28 (v544-v5)
        • Prado C.M.
        • Baracos V.E.
        • McCargar L.J.
        • Reiman T.
        • Mourtzakis M.
        • Tonkin K.
        • et al.
        Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
        Clin Cancer Res. 2009; 15: 2920-2926
        • Ruan X.
        • Wang X.
        • Zhang Q.
        • Nakyeyune R.
        • Shao Y.
        • Shen Y.
        • et al.
        The performance of three nutritional tools varied in colorectal cancer patients: a retrospective analysis.
        J Clin Epidemiol. 2022; 149: 12-22
        • Song H.-N.
        • Wang W.-B.
        • Luo X.
        • Huang D.-D.
        • Ruan X.-J.
        • Xing C.-G.
        • et al.
        Effect of GLIM-defined malnutrition on postoperative clinical outcomes in patients with colorectal cancer.
        Jpn J Clin Oncol. 2022; 52: 466-474
        • Beukers K.
        • Bessems S.A.M.
        • van de Wouw A.J.
        • van den Berkmortel F.
        • Belgers H.J.
        • Konsten J.L.M.
        • et al.
        Associations between the Geriatric-8 and 4-meter gait speed test and subsequent delivery of adjuvant chemotherapy in older patients with colon cancer.
        J Geriatr Oncol. 2021; 12: 1166-1172
        • Lyman G.H.
        • Michels S.L.
        • Reynolds M.W.
        • Barron R.
        • Tomic K.S.
        • Yu J.
        Risk of mortality in patients with cancer who experience febrile neutropenia.
        Cancer. 2010; 116: 5555-5563
        • Lee C.S.
        • Ryan E.J.
        • Doherty G.A.
        Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation.
        World J Gastroenterol: WJG. 2014; 20: 3751